Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors

Brauker, James H.; Matsubara, Bradley S.

doi:10.2337/dc08-1037

Search citation statements

Order By: Relevance

Paper Sections

Select...

Accuracy Of Continuous Glucose Monitors1

Mechanism and Accuracy1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2008

2012

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There was a concern regarding a transient loss of sensitivity during hypoglycemia, which, in some cases, may have been improved with later models of devices. 18 Murphy and colleagues 19 examined accuracy of CGM to plasma glucose and found the MARD to be 13.3% in 10 pregnant patients with T1DM. A total of 94.6% of CGM values were in a clinically acceptable zone (no overcorrection errors or unsafe glucose levels).…”

Section: Accuracy Of Continuous Glucose Monitorsmentioning

confidence: 99%

Continuous Glucose Monitoring in Pregnancy: New Frontiers in Clinical Applications and Research

Sung

Taslimi

Faig

2012

J Diabetes Sci Technol

View full text Add to dashboard Cite

show abstract

Section: Accuracy Of Continuous Glucose Monitorsmentioning

confidence: 99%

Continuous Glucose Monitoring in Pregnancy: New Frontiers in Clinical Applications and Research

Sung

Taslimi

Faig

2012

J Diabetes Sci Technol

View full text Add to dashboard Cite

show abstract

“…MARD and MedARD are the absolute differences expressed as a percentage of the reference blood glucose values (9). Finally, the International Standards Organization (ISO) criteria call for the percentage of CGM readings within 0.8 mmol/liter from reference when the reference is less than 4.2 mmol/liter or within 20% from reference when the reference is more than 4.2 mmol/liter (10).…”

Section: Mechanism and Accuracymentioning

confidence: 99%

Realistic Expectations and Practical Use of Continuous Glucose Monitoring for the Endocrinologist

Hirsch

2009

The Journal of Clinical Endocrinology &Amp; Metabolism

View full text Add to dashboard Cite

Accuracy of this technology has improved in the short amount of time it has been available. Six-month data suggest that patient selection is a key for success. Patients who do not understand or practice the basics of intensive insulin therapy have the greatest challenges. Those who do best watch the receiver frequently, continue with frequent home blood glucose monitoring, use the trending information to make insulin adjustments, and understand the limitations of the technology. With insurance reimbursement improving, CGM is gaining acceptance as an important tool for the management of type 1 diabetes. Like home blood glucose monitoring and insulin pump therapy, this technology by itself is not a panacea for diabetes control. However, it further adds to our ability to improve the lives of people with diabetes. Long-term, the hope is that this technology will pave the way for a "closed-loop" device.

show abstract